• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.

作者信息

Trébucq A, Rieder H L

机构信息

International Union Against Tuberculosis and Lung Disease, Paris, France.

出版信息

Int J Tuberc Lung Dis. 1998 Mar;2(3):184-6.

PMID:9526189
Abstract
摘要

相似文献

1
Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.国家结核病规划的两个出色管理工具：既往治疗史和两个月时的痰检状况
Int J Tuberc Lung Dis. 1998 Mar;2(3):184-6.
2
Tuberculosis treatment: dangerous regimens?结核病治疗：危险的治疗方案？
Int J Tuberc Lung Dis. 2001 Jan;5(1):1-3.
3
[Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)].[肺结核的间歇化疗（文献综述）]
Probl Tuberk. 1978 Oct(10):23-8.
4
[Short-course treatment of pulmonary tuberculosis: comparison with a classical standard regimen].[肺结核的短程治疗：与经典标准方案的比较]
Bull Int Union Tuberc. 1985 Mar-Jun;60(1-2):29-30.
5
[Fully supervised ambulatory short-course chemotherapy with an intermittent regimen for newly diagnosed smear-positive pulmonary tuberculosis].[新诊断涂片阳性肺结核全程督导间歇方案门诊短程化疗]
Zhonghua Jie He He Hu Xi Za Zhi. 1987 Oct;10(5):261-3, 307.
6
[Comparison of a 6-month chemotherapy and a l2-month chemotherapy in the treatment of pulmonary tuberculosis in Algerian Sahara. Cooperative study by an Algerian work team and the British Medical Research Council].[6个月化疗与12个月化疗治疗阿尔及利亚撒哈拉地区肺结核的比较。阿尔及利亚工作团队与英国医学研究理事会的合作研究]
Bull Int Union Tuberc. 1985 Mar-Jun;60(1-2):31-3.
7
[Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)].[结核病的短期化疗。对含吡嗪酰胺的18周治疗方案的评估（初步结果）]
Bull Int Union Tuberc. 1978 Dec;53(4):260-1.
8
[Long-term results of short-course chemotherapy in pulmonary tuberculosis (final report). The third study: comparative study of two regimens, 6RHZ and -6RHS (treatment was continued for 6 months after negative conversion of sputum by culture)].
Kekkaku. 1988 Apr;63(4):239-46.
9
[Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy].[短程化疗后涂片阴性肺结核复发的随访观察]
Zhonghua Jie He He Hu Xi Za Zhi. 2003 Feb;26(2):74-6.
10
[Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].[利福平与异烟肼分别联合乙胺丁醇或链霉素及吡嗪酰胺用于新发现肺结核短期化疗的各种组合的副作用]
Pneumonol Pol. 1980 Jul;48(7):469-79.

引用本文的文献

1
An Evaluation of Treatment Outcomes in a Cohort of Clients on the DOTS Strategy, 2012-2016.2012 - 2016年对采用直接观察治疗短程化疗策略的一组患者的治疗结果评估。
Tuberc Res Treat. 2018 Feb 15;2018:4287842. doi: 10.1155/2018/4287842. eCollection 2018.
2
A Retrospective Analysis of Two-Month Sputum Smear Non-Conversion in New Sputum Smear Positive Tuberculosis Patients in the Free State Province, South Africa.南非自由邦省新痰涂片阳性结核病患者两个月痰涂片未转阴情况的回顾性分析
J Public Health Afr. 2014 Jul 9;5(2):324. doi: 10.4081/jphia.2014.324. eCollection 2014 Jun 29.
3
Risk factors for tuberculosis smear non-conversion in Eden district, Western Cape, South Africa, 2007-2013: a retrospective cohort study.
2007 - 2013年南非西开普省伊登地区结核涂片未转阴的危险因素：一项回顾性队列研究
BMC Infect Dis. 2016 Aug 2;16:365. doi: 10.1186/s12879-016-1712-y.
4
Sex-related trends in non-conversion of new smear-positive tuberculosis patients in the Free State, South Africa.南非自由州新涂片阳性结核病患者未治愈的性别相关趋势。
Public Health Action. 2014 Mar 21;4(1):66-71. doi: 10.5588/pha.13.0108.
5
Characteristics and outcomes of tuberculosis patients who fail to smear convert at two months in Sri Lanka.斯里兰卡两个月痰涂片仍未转阴的结核病患者的特征及转归
Public Health Action. 2013 Mar 21;3(1):26-30. doi: 10.5588/pha.12.0090.